Litcius/Paper detail

Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19

Fu-Mao Zhang, Ting Huang, Feng Wang, Gui-Shan Zhang, Donglan Liu, Jun Dai, Jianwei Zhang, Qinghua Li, Guo‐Qiang Lin, Dingding Gao, Jincun Zhao, Ping Tian

2023European Journal of Medicinal Chemistry19 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryVero cellCoronavirusProteasesCysteine proteaseCathepsinDeubiquitinating enzymeCathepsin LBiochemistryPeptidomimeticCysteineCovalent bondCathepsin DVirologyCoronavirus disease 2019 (COVID-19)EnzymePeptideIn vitroBiologyInfectious disease (medical specialty)UbiquitinMedicineGeneDiseaseOrganic chemistryPathologyComputational Drug Discovery MethodsSynthesis and biological activityClick Chemistry and Applications